The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

Multi-stakeholder discussions

CDDF Spring/Autumn Conference

The CDDF Spring/Autumn Conference, the successor of the former Alpine Conference, is held every 18 months in the Netherlands. This meeting takes stock of achievements and brainstorms upcoming issues in cancer drug development and gauges whether there is interest in running workshops on different topics. It also gathers the leaders in the world of innovative cancer therapy development, including medical researchers, pharmaceutical industry representatives, regulatory authority representatives as well as patient advocacy groups.

The 11th edition takes place from 10 to 12 February 2020, in Noordwijk aan Zee, the Netherlands. It will focus on the latest and future challenges of Innovative oncology drug development with a special emphasis on rational combination therapies, tumor agnostic drug development, cell therapy, and the new EMA Anti-cancer Guideline.

 

CDDF multi-stakeholder workshops:

In addition to the Spring/Autumn conference, the CDDF organizes separate workshops to address topical issues in the cancer research field such as biomarkers, minimal residual disease, oncology clinical trial design and innovative oncology drug, encouraging a unique collaborative approach.

 

Willing to join our initiative?

If you are willing to join our initiatives, please feel free to contact the CDDF office at any time. We count on your engagement to move forward together.

Cancer Drug Development Forum
c/o BLSI
Clos Chapelle-aux-Champs 30
1200 Brussels, Belgium

info@cddf.org
Tel: +32 2 880 62 70

Legal address
c/o Deloitte Tirol
Wirtschaftsprüfungs GmbH,
Wilhelm-Greil-Str. 15,
6020 Innsbruck, Austria